nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allele-selective inhibition of trinucleotide repeat genes
|
Matsui, Masayuki |
|
2012 |
17 |
9-10 |
p. 443-450 8 p. |
artikel |
2 |
A network-based approach to quantifying the impact of biologically active substances
|
Hoeng, Julia |
|
2012 |
17 |
9-10 |
p. 413-418 6 p. |
artikel |
3 |
Applications of saturation transfer difference NMR in biological systems
|
Bhunia, Anirban |
|
2012 |
17 |
9-10 |
p. 505-513 9 p. |
artikel |
4 |
A series of case studies: practical methodology for identifying antinociceptive multi-target drugs
|
Pang, Min-Hee |
|
2012 |
17 |
9-10 |
p. 425-434 10 p. |
artikel |
5 |
Bridging solubility between drug discovery and development
|
Di, Li |
|
2012 |
17 |
9-10 |
p. 486-495 10 p. |
artikel |
6 |
Can efficient delivery systems leverage benefits of antioxidants leading to potential medicines?
|
Ravi Kumar, M.N.V. |
|
2012 |
17 |
9-10 |
p. 407-408 2 p. |
artikel |
7 |
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
|
Morgan, Paul |
|
2012 |
17 |
9-10 |
p. 419-424 6 p. |
artikel |
8 |
Can we vaccinate against depression?
|
Rook, Graham A.W. |
|
2012 |
17 |
9-10 |
p. 451-458 8 p. |
artikel |
9 |
Compilation of 222 drugs’ plasma protein binding data and guidance for study designs
|
Zhang, Fengling |
|
2012 |
17 |
9-10 |
p. 475-485 11 p. |
artikel |
10 |
Contact lenses in ocular therapeutics
|
Gupta, Himanshu |
|
2012 |
17 |
9-10 |
p. 522-527 6 p. |
artikel |
11 |
Contents
|
|
|
2012 |
17 |
9-10 |
p. i- 1 p. |
artikel |
12 |
Contents
|
|
|
2012 |
17 |
9-10 |
p. iii- 1 p. |
artikel |
13 |
Kinase activators as a novel class of antidiabetic agents
|
Castro, Ana |
|
2012 |
17 |
9-10 |
p. 528-529 2 p. |
artikel |
14 |
Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)
|
Cvek, Boris |
|
2012 |
17 |
9-10 |
p. 409-412 4 p. |
artikel |
15 |
Systems chemical biology and the Semantic Web: what they mean for the future of drug discovery research
|
Wild, David J. |
|
2012 |
17 |
9-10 |
p. 469-474 6 p. |
artikel |
16 |
Targeting cancer-initiating cell drug-resistance: a roadmap to a new-generation of cancer therapies?
|
Alama, Angela |
|
2012 |
17 |
9-10 |
p. 435-442 8 p. |
artikel |
17 |
Therapeutic potential for novel ultra long-acting β2-agonists in the management of COPD: biological and pharmacological aspects
|
Malerba, Mario |
|
2012 |
17 |
9-10 |
p. 496-504 9 p. |
artikel |
18 |
Translational semantics and infrastructure: another search for the emperor's new clothes?
|
Mullane, Kevin |
|
2012 |
17 |
9-10 |
p. 459-468 10 p. |
artikel |
19 |
Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies
|
Esmail, Hanif |
|
2012 |
17 |
9-10 |
p. 514-521 8 p. |
artikel |